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Abstract
BACKGROUND: Therapies for diabetes mellitus are still meeting failure in most cases, especially in the developed 
stages of the disease due to incredible associating complications. Hence, there is a need for continuous development 
of curative therapies for that stubborn disease.
AIM: We aimed to investigate the antidiabetic effects of one of the most popular plants cultivated in Egypt, C. olitorius. 
METHODS: Phytochemical screening of total alcoholic extract of Corchorus olitorius leaves and its aqueous and 
chloroform fractions revealed the presence of flavonoids, saponins, carbohydrates, tannins, coumarins, and alkaloids.
RESULTS: The gas chromatography-mass spectrometry analysis showed the presence of 12 and nine chemical 
compounds in aqueous and chloroform extracts, respectively. C. olitorius decreased serum glucose level and 
α-amylase activity. This effect was more pronounced in the total alcoholic extract and its chloroform fraction than the 
aqueous one. The extracts also adjusted the lipid profile, reduced liver injury parameters, and caused remarkable 
improvement and increase number, size, and density of functioning β-cells. 
CONCLUSION: The findings suggest the antihyperglycemic and antioxidant effects of C. olitorius besides its beneficial 
effect on diabetic complications such as hyperlipidemia and liver injury. The presence of some phytochemicals 
such as theophylline, trans-2, 3-dimethoxycinnamic acid, 7-hydroxy-4-methyl coumarin, apigenin 7-glucoside, and 
glycitein may contribute to such pharmacological effects.
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Introduction
Type 1 diabetes is a chronic disease that 
is associated with several long-term complications, 
including microvascular and macrovascular events 
such as neuropathy, hyperlipidemia, nephropathy, and 
retinopathy. Nowadays, the life expectancy of type 1 
diabetic patients is still about 12 years less than that 
of the general population [1]. The burden of long-
term care and increased morbidity necessitate more 
studies to prevent, treat and even achieve a true cure 
for this complicated disease. In fact, the improvements 
achieved in insulin delivery systems provided better 
control of blood glucose; however, there is a continuing 
demand for newer therapies to cope with the devastating 
complications that occur alongside [2].
Corchorus olitorius L. belongs to family 
Tiliaceae and known as “Jute,” which is characterized 
by the presence of high ratios of amino acids; hence, 
it is an essential source of dietary protein in Egypt and 
many other countries. Leaves of C. olitorius are edible 
and its ethnic soup is well-known in Egypt under the 
name of “Molukhyia.” The leaves were found to be 
rich sources of ω3-octadecatriene fatty acid which is 
a higher concentration than any other vegetable [3]. 
The plant has been reported to possess anti-
inflammatory [4], antibacterial, demulcent, bitter tonic, 
laxative, carminative, diuretic, useful in chronic cystitis, 
gonorrhea, and cardiotonic [5], [6]. In previous recent 
studies, it was shown that the ethanolic seed extract of 
C. olitorius was effective as an antidiabetic remedy [7] 
and leaf extract showed antihyperglycemic effects in 
type 2 diabetic animal model [8].
The present study aims to investigate the 
antidiabetic effects of C. olitorius different leaf extracts 
using Type 1 diabetic animal model that will be induced 
by streptozotocin (STZ). A comparative pharmacological 
study will be performed for the first time between the 
three extracts; the total alcoholic and its two fractions 
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(chloroform and aqueous) to find if the antidiabetic effect 
of the C. olitorius is ascribed to nonpolar (dissolved in 
chloroform fraction), polar compounds (dissolved in 
aqueous fraction) alone or due to total extract. Gas 
chromatography-mass spectrometry (GC-MS) analysis 
was used also to identify the potential bioactive 
phytochemicals in those two fractions.
Materials and Methods
Chemicals
Gliclazide (standard antidiabetic drug) 
was purchased from SERVIER subsidiary SERDIA 
Pharmaceuticals (Canada) in tablet form, grounded 
using a mortar, and dissolved in distilled water. 
Chloroform and methanol (purity: 95–99%) were 
purchased from El-Gomhouria Co. (Egypt). STZ was 
purchased from Sigma-Aldrich Chemie GmbH Co. 
(Germany).
Collection and identification of the plant 
material
C. olitorius leaves that used in the study were 
supplied by Haraz flour Milling, Cairo, Egypt. C. olitorius 
leaves were cleaned and stored in a cool and dry place 
before use. A voucher specimen (Reg. No.: Co, 2013-
80) was deposited in the herbarium of Pharmacognosy 
Department, Faculty of Pharmacy, Al-Azhar University 
and it was air-dried and kept in a tightly closed container.
Preliminary phytochemical investigation
Phytochemical screening was performed using 
standard procedures based on colorimetric tests [9], 
[10]. C. olitorius leaves were screened for the presence 
of carbohydrates, saponins and/or glycosides, alkaloids, 
anthraquinones, unsaturated sterols, triterpenes, 
coumarins, tannins, cardiac glycosides, and flavonoids. 
The phytochemical screening revealed the presence of 
all the previous phytochemicals except anthraquinones 
and volatile compounds.
Preparation of extract
The powdered plant materials (1.5 kg) were 
extracted with ethanol (70%) (1 L/time). The extraction 
was done by a hot continuous percolation method in 
the Soxhlet apparatus for 24 h [11]. The extract was 
concentrated using a rotary evaporator till dry powder 
was obtained (~150 g). The total extract was dissolved 
at least amount water, extracted by chloroform (3 × 1 
L). Using separating funnel, the organic layer and the 
aqueous layer were separated, and then two fractions 
were concentrated using a rotary evaporator till dry 
powder was obtained (40 g of chloroform and 95 g of 
aqueous fractions). The final residues thus obtained 
were then subjected to GC-MS analysis [12].
GC-MS analysis
The chloroform and aqueous fractions of 
C. olitorius leaves were analyzed through GC-MS 
for the identification of different compounds. The 
GC-MS analysis was carried out using a GC (Agilent 
Technologies 7890A) interfaced with a mass selective 
detector (MSD, Agilent 7 000) equipped with a polar 
Agilent HP-5ms (5%-phenyl methyl polysiloxane) 
capillary column (30 m × 0.25 mm i.d. and 0.25 µm film 
thickness). The oven temperature was programmed 
initially at 40°C (for 3 min) to 280°C final at an increasing 
rate of 5°C/min (for 5 min). The carrier gas was helium 
with a linear velocity of 1 mL/min. The electron ionization 
system with ionization energy of 70 eV was used.
The identification of components
Interpretation of the mass spectrum of 
GC-MS was based on using the database of the 
National Institute Standard and Techniques (NIST 
Version, 2008), which have more patterns. The 
relative percentage amount of each component was 
calculated by comparing its average peak area to the 
total areas. The spectrum of the unknown compound 
was compared with the spectrum of the compound 
stored in the NIST data library (NIST08s), WILEY8, 
and Adams. The name, molecular weight, molecular 
formula, and structure of the components of the test 
material were obtained.
Assessment of antidiabetic activity
Animals
Healthy male Wistar rats, weighing 200–220 g, 
were obtained from the animal house of the National 
Research Centre. Before initiating the experiments, the 
rats were allowed to acclimatize for a few days under 
standard environmental conditions (12 h dark/12 h light 
cycle; temperature 20–22°C; relative humidity 40–60%). 
The animals were cared for in accordance with the Guide 
to the Care and Use of Experimental Animals available 
from the Canadian Council on Animal Care. The ethical 
standards of the experiment are also in accordance 
with the guidelines provided by the CPCSEA and World 
Medical Association Declaration of Helsinki on Ethical 
Principles for Medical Research. The animal use was 
approved and conducted according to regulations of 
the ethics committee of the National Research Centre 
which gave its consent in accordance with the National 
Regulations on Animal Welfare and Institutional Animal 
Ethical Committee (Approval No: 17-062).
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Induction of diabetes and animal grouping
Type 1 diabetes mellitus was induced by a 
single i.p. injection of a freshly prepared solution of STZ 
(52.5 mg/kg body weight) in 0.1 M citrate buffer (pH 4.3) 
after a fasting period of 24 h [13]. On the 3rd day of STZ 
injection, blood was collected from tail veins of rats 
and glucose level was measured. Rats with a serum 
glucose level of 180 mg/dL or greater were considered 
diabetic and selected in this study. A group of six rats 
was kept as a negative control group and received 1 mL 
saline orally (Group 1). After induction of diabetes, rats 
were divided into other eight equal groups (six rats per 
group). Group 2 (positive control) received STZ only, as 
mentioned above. Group 3 received oral administration 
of the reference drug (gliclazide, 10 mg/kg). Groups 4–9 
rats were administered C. olitorius at two different oral 
doses; 50 and 100 mg/kg as reported in literature [14] 
as follows: Groups 4 and 5 received STZ and C. 
olitorius total alcoholic extract at two dose levels: 50 and 
100 mg/kg bw, respectively. Groups 6 and 7 received 
C. olitorius aqueous extract at 50 and 100 mg/kg bw, 
respectively. Groups 8 and 9 received C. olitorius 
chloroform extract at 50 and 100 mg/kg bw, respectively.
Treatment with C. olitorius extracts was started 
3 days after STZ injection and lasted for 14 days. At the 
end of the experiment, blood samples were drawn from 
the tail veins of rats [15] for recording fasting serum 
glucose in each group on days 3 (beginning of diabetes 
induction) and 17 (last day of the experiment, after 
treatment) of the study. Serum glucose was measured 
using glucose kit (Stanbio Laboratory, USA), according 
to Trinder [16]. Serum samples were obtained by 
centrifugation at 3 000 rpm for 10 min using the 
cooling centrifuge (Sigma and Laborzentrifugen, 2 k15, 
Germany) and used for biochemical measurements.
Biochemical assay
The collected sera were used for the 
determination of α-amylase, total antioxidant capacity 
(TAC), total cholesterol, triglycerides level, LDL, HDL, 
AST, and ALT using specific kits (Chronolab, Spain). The 
procedures were done according to the manufacturer’s 
instructions. Percent of change of each indicator from 
positive control (STZ diabetic group) was calculated 
according to the following formula:
% change = [(Conc. in STZ group−Conc. in 
treated group)/Conc. in STZ group]*100
Histopathological examination
After sacrifice, animal organs (pancreas or liver) 
were dissected, extracted, and immediately fixed in buffered 
formalin. Tissues were further dehydrated, embedded 
into paraffin blocks, and serially sectioned at 4 microns 
thickness. Paraffin sections were stained with hematoxylin 
and eosin for routine histopathological study [17].
Further paraffin sections were stained 
immunohistochemically with insulin mouse Monoclonal 
Antibody INS05 (2D11-H5)-Thermo-Fisher.
Stained sections were examined using the light 
microscope OLYMPUS CX41 and photomicrographs 
were taken using digital camera OLYMPUS DP12.
Statistical analysis
All studied data were statistically analyzed 
using GraphPad Software Computer Program; version 6 
hypothesis testing methods included one-way analysis 
of variance (ANOVA) using the Tukey test as post hoc 
test. Data were represented as mean±SEM. p ≤ 0.05 
was considered to be statistically significant.
Results
GC-MS analysis
GC-MS chromatogram of the aqueous 
extract showed 12 peaks indicating the presence of 
12 phytochemical compounds, and the chromatogram 
of the chloroform extract showed nine phytochemical 
compounds. The mass spectra of identified 
compounds were matched with those found in NIST/
NBS spectral database given in Tables 1 and 2. 
Table 1: Phytochemical compound identified in aqueous extract 
of leaves of Corchorus olitorius L.
RT Name of the compound Molecular 
formula
Molecular 
weight
Peak 
area (%)
3.49 Levoglucosenone C6H6O3 126 5.0
3.76 6-Acetyl-β-D-mannose C8H14O7 222 14.0
9.78 Ascaridole epoxide C10H16O3 184 1.8
9.96 2-(2-Methyl-propenyl)-cyclohexanone C10H16O 152 1.3
10.98 D-lyxo-D-manno-nononic-1,4-lactone C9H16O9 268 0.5
11.77 N-acetyl-D-galactosaminitol C8H17NO6 223 0.9
13.52 Digitoxin C41H64O13 764 4.2
14.07 1-Deoxy-1-(methylamino) hexitol C7H17NO5 195 5.4
15.05 Theophylline C7H8N4O2 180 7.2
17.58 Trans-2,3-dimethoxycinnamic acid C11H12O4 208 2.0
20.08 Isoelemicin C12H16O3 208 1.7
21.45 Nabilone C24H36O3 372 6.2
The identification of the phytochemical 
compounds was confirmed based on the peak area, 
retention time, and molecular formula. The individual 
fragmentation patterns of necessary compounds were 
illustrated in Figure 1.
Table 2: Phytochemical compound identified in chloroform 
extract of leaves of Corchorus olitorius L.
RT Name of the compound Molecular 
formula
Molecular 
weight
Peak area 
(%)
9.75 7-Hydroxy-4-methyl coumarin C10H8O3 176 0.32
10.19 3,4-Dimethoxycinnamic acid C11H12O4 208 0.34
10.84 D-saccharic acid 1,4-lactone C6H8 O7H2O 210 0.41
12.60 Camphoric acid C10H16O4 200 3.80
13.84 Apigenin 7-glucoside C21H20O10 432 4.36
13.90 β-tocopherol C28H48O2 416 0.99
15.03 3-Oxo-7,8-dihydro-α-ionol C13H22O2 210 11.56
15.46 4-Hydroxy-2-methoxybenzaldehyde C8H8O3 152 30.95
15.58 Glycitein C16H12O5 284 1.33
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Biochemical assay
Effect on fasting glucose level
As shown in Table 3, initial serum glucose was 
significantly increased (p < 0.05) in all STZ-treated 
groups as compared to the negative control one 
(confirming diabetes). At the end of the experiment, 
glucose level was significantly increased (p < 0.05) in 
the diabetic group exhibiting 24% increase from the 
initial value. After C. olitorius administration, glucose 
level was significantly decreased (p < 0.05) in gliclazide 
(standard drug), total alcoholic C. olitorius extract 
(100 mg/kg), aqueous (100 mg/kg), and chloroform 
C. olitorius fractions (50 and 100 mg/kg) by 66%, 
65%, 38%, 66%, and 50%, respectively, compared 
to STZ-diabetic group. It is worthy to note that total 
alcoholic and aqueous extracts decreased glucose 
level in a dose-dependent manner.
Effect on α amylase activity
Table 3 obviously showed that the activity of 
α amylase in the STZ-diabetic group was increased 
significantly (p < 0.05) compared to the negative 
control. The activity of α amylase was decreased in 
animal groups treated with gliclazide, total C. olitorius 
extract (100 mg/kg), aqueous C. olitorius fraction 
(100 mg/kg), and chloroform C. olitorius fractions 
(50 and 100 mg/kg) by 12%, 9%, 9%, 12%, and 8%, 
Figure 1: The individual fragmentation pattern of the important compounds in gas chromatography analysis. (a) Theophylline, (b) Trans-2,3-
dimethoxycinnamic acid, (c) 7-Hydroxy-4-methyl coumarin, (d) Digitoxin, (e) Apigenin 7-glucoside, (f) Glycitein
dc
b
f
a
e
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respectively, compared to STZ-diabetic group and 
returned to normal value. The effects of two doses (50 
and 100 mg/kg) were significantly different in the groups 
treated with total alcoholic and aqueous extracts. From 
the data represented in the table, an inhibition in α 
amylase activity was more pronounced in the group 
treated with chloroform C. olitorius fraction (50 mg/kg) 
and gliclazide.
Effect on TAC
TAC was significantly decreased (p < 0.05) 
in the positive control group compared to the negative 
control group. Treatment with gliclazide, total alcoholic 
C. olitorius extract (100 mg/kg), and chloroform 
C. olitorius fractions (50 and 100 mg/kg) normalized 
TAC as shown in Table 3. The groups treated with total 
alc extract at different doses were significantly different 
from each other. The TAC increased by 12%, 11%, 
13%, and 14% in the previous groups, respectively, 
compared to the STZ-diabetic group.
Effect on lipid profile
Lipid profile is presented in Table 4. Cholesterol 
and triglycerides levels increased significantly (p < 0.05) 
in diabetic groups as compared to the negative control 
group. Levels of cholesterol and triglycerides 
decreased significantly (p < 0.05) in animals treated 
with C. olitorius total alcoholic extract and its fractions 
except for triglycerides level in the group treated with 
the total alcoholic extract (100 mg/kg) and gliclazide 
comparing to diabetic group. Levels approached that 
of the negative control group in animals treated with 
aqueous and chloroform fractions of C. olitorius at 
both dose levels (except for the total cholesterol value 
in the group treated with aqueous extract; 50 mg/kg) 
which exerted 42%, 64%, 46%, and 50% decrease in 
total cholesterol level and 59%, 62%, 55%, and 61% 
decrease in triglycerides level, respectively, compared 
to STZ-diabetic group. Whereas, gliclazide treatment 
decreased cholesterol and triglycerides level by 44% and 
42%, respectively, compared to the STZ-diabetic group. 
For cholesterol, aqueous extract (50 mg/kg) treatment 
showed a significant difference from the group treated 
with the same extract at 100 mg/kg. HDL-cholesterol 
level significantly (p < 0.05) decreased in the STZ-
treated group as compared to the negative control. HDL-
cholesterol showed a remarkable increase in all extract 
treatment groups (p < 0.05) compared to the diabetic 
group and its level was higher than the normal value. 
Whereas, LDL-cholesterol level increased significantly 
(p < 0.05) in the diabetic group compared to the negative 
control group. After C. olitorius administration, LDL-
cholesterol levels were decreased in all treated groups 
(p < 0.05) compared to the diabetic group except for the 
aqueous extract (50 mg/kg) treated group. The highest 
decrease was observed in the chloroform fraction 
treated groups (50 and 100 mg/kg) which were 21% and 
20% when compared to the STZ-diabetic group. There 
was no significant difference in LDL-cholesterol levels 
in all treatment groups as compared to the negative 
control group.
Effect on liver enzymes
As illustrated in Table 5, ALT and AST revealed 
a significant increase (p < 0.05) in the positive control 
group compared to the negative control. Administration 
of the different extracts of C. olitorius showed a 
significant decrease (p < 0.05) in ALT and AST activities 
compared to the positive control group. ALT activity was 
decreased by 23%, 35%, 40%, 52%, 40%, and 50% 
after administration of total alcoholic extract (50 and 
100 mg/kg), aqueous extract (50 and 100 mg/kg), and 
chloroform fraction (50 and 100 mg/kg), respectively. 
The effect on AST activity was more pronounced in the 
Table 4: Effect of Corchorus olitorius on serum lipid profile 
(mg/dL)
Treatment Total cholesterol Triglycerides LDL HDL
Control negative 
(normal)
89.17 ± 1.00a 48.79 ± 1.50a 37.60 ± 0.30a 39.80 ± 3.51a
Control positive 
(STZ, 52.5 mg/kg)
199.20 ± 12.30* 146.60 ± 6.30* 44.50 ± 1.50* 22.89 ± 1.46*
Gliclazide (10 mg/kg) 110.50 ± 5.20a 85.30 ± 3.20*a 37.90 ± 0.60a 37.10 ± 0.72a
C. olitorius tot alc ext  
(50 mg/kg)
132.70 ± 2.60*a  65.20 ± 4.80a 38.10 ± 1.90a 50.78 ± 3.18a
C. olitorius tot alc ext  
(100 mg/kg)
129.00 ± 1.30*a 73.67 ± 5.10* 37.80 ± 0.60a 47.09 ± 4.34a
C. olitorius aqueous 
ext (50 mg/kg)
114.90 ± 5.40*a 60.64 ± 4.20a 41.60 ± 1.10 58.75 ± 4.15*a
C. olitorius aqueous 
ext (100 mg/kg)
71.33 ± 2.30a,d 55.87 ± 3.10a,d 38.20 ± 1.60a 46.42 ± 2.23a
C. olitorius chloroform 
ext (50 mg/kg)
108.00 ± 6.50a 66.50 ± 1.70a 35.20 ± 1.00a 52.25 ± 1.61a
C. olitorius chloroform 
ext (100 mg/kg)
100.30 ± 2.80a 57.37 ± 5.30a 35.40 ± 1.00a 50.98 ± 2.96a
Each value represents the mean±SEM (n = 6). *Significantly different from control negative (saline) at 
p<0.05, aSignificantly different from control positive (STZ) at p<0.05. bSignificantly different from tot alc ext 
(50 mg/kg). cSignificantly different from tot alc ext (100 mg/kg). dSignificantly different from aqueous ext 
(50 mg/kg). Statistical analysis was carried out using one-way ANOVA test followed by Tukey post hoc test. 
C. olitorius: Corchorus olitorius, LDL: Low-density lipoprotein, HDL: High-density lipoprotein.
Table 3: Effect of Corchorus olitorius L. on serum glucose, α 
amylase, and TAC
Treatment Glucose (initial) 
(mg/dL)
Glucose (final) 
(mg/dL)
α-amylase 
activity (U/L)
TAC (mMol/L)
Control negative 
(normal)
101.80 ± 4.70a 106.0 ± 3.8a 1162.0 ± 6.1a 2.64 ± 0.02a
Control positive 
(STZ, 52.5 mg/kg)
424.40 ± 18.10* 558.4 ± 26.1* 1284.0 ± 4.9* 2.33 ± 0.04*
Gliclazide  
(10 mg/kg)
410.60 ± 20.10* 187.5 ± 10.1a 1130.0 ± 8.2a 2.61 ± 0.05a
C. olitorius tot alc 
ext (50 mg/kg)
428.20 ± 38.90* 582.7 ± 35.6* 1269.0 ± 38.5*c 2.30 ± 0.02*c
C. olitorius tot alc 
ext (100 mg/kg)
325.30 ± 24.80* 190.5 ± 5.4a,b 1170.0 ± 18.6a,b 2.60 ± 0.05a,b
C. olitorius 
aqueous ext  
(50 mg/kg 
378.60 ± 27.20* 490.6 ± 22.1* 1266.0 ± 16.2* 2.45 ± 0.02*
C. olitorius 
aqueous ext  
(100 mg/kg)
366.50 ± 34.00* 346.7 ± 27.7*a,d 1169.0 ± 11.8ad 2.35 ± 0.04*
C. olitorius 
chloroform ext 
(50 mg/kg)
379.10 ± 37.70* 191.6 ± 6.2a 1135.0 ± 7.6 2.64 ± 0.03a
C. olitorius 
chloroform ext  
(100 mg/kg)
332.50 ± 13.56* 279.2 ± 22.5*a 1183.0 ± 3.2a 2.65 ± 0.03a
Each value represents the mean±SEM (n=6). *Significantly different from control negative (saline) at 
p<0.05, aSignificantly different from control positive (STZ) at p<0.05. bSignificantly different from tot alc ext 
(50 mg/kg). cSignificantly different from tot alc ext (100 mg/kg). dSignificantly different from aqueous ext 
(50 mg/kg). Statistical analysis was carried out using one-way ANOVA test followed by Tukey post hoc test. 
TAC: Total antioxidant capacity, STZ: Streptozotocin, C. olitorius: Corchorus olitorius.
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group treated with the total alcoholic extract (50 mg/kg). 
The improvement in biochemical parameters achieved 
by C. olitorius extracts was comparable to the standard 
antidiabetic drug gliclazide.
Histopathological findings
The histologic appearance of the pancreatic 
tissues of the negative control rats showed that normal 
islets of Langerhans are surrounded by ordinary 
pancreatic acini. Islets were regular with well-defined 
boundaries. Cells within islets showed oval to rounded 
nuclei, disposed in organized architecture. Surrounding 
pancreatic acini were lined by pyramidal cells showing 
ample apical cytoplasm and rounded, bland, basophilic 
basoluminal nuclei (Figure 2a). The pancreas of diabetic 
untreated rats showed disruption of the architecture 
and microstructure within the islets of Langerhans. 
Prominent vacuolar degeneration was observed 
with focal necrosis. Karyolysis was seen with foci of 
pyknosis and scattered eosinophilic bodies. Changes 
were most prominent at the center of the islets. Islets 
also showed irregularity in their shape and appeared 
small and shrunken (Figure 2b). Scattered islets 
showed dense inflammatory cellular infiltrate (insulitis). 
Outside the islets of Langerhans, the pancreatic ductal 
and acinar epithelium appeared normal. Treatment with 
reference drug (gliclazide) showed improvement in size, 
cellularity, and architectural arrangement within islets, 
approximating negative control (Figure 2c). Treatment 
with total alcoholic extract (100 mg/kg) caused 
remarkable improvement in the pancreas (Figure 2e); 
Table 5: Effect of Corchorus olitorius L. on serum liver enzymes 
(U/L)
Treatment ALT AST
Control negative (normal) 114.5 ± 5.3a 155.5 ± 1.9a
Control positive (STZ, 52.5 mg/kg) 221.2 ± 16.3*  253.5 ± 12.3*
Gliclazide (10 mg/kg) 175.3 ± 6.2*a 220.1 ± 19.1*a
C. olitorius Tot alc ext (50 mg/kg) 169.7 ± 7.4*a 182.5 ± 2.4a
C. olitorius Tot alc ext (100 mg/kg) 143.3 ± 7.6a 212.8 ± 2.6*a
C. olitorius aqueous ext (50 mg/kg) 135.2 ± 9.6a 213.1 ± 8.6*a
C. olitorius aqueous ext (100 mg/kg) 105.2 ± 3.2a 210.1 ± 6.4*a
C. olitorius Chloroform ext (50 mg/kg) 133.3 ± 3.2a 217.6 ± 7.0*a
C. olitorius Chloroform ext (100 mg/kg) 109.3 ± 5.4a 218.5 ± 4.4*a
Each value represents the mean±SEM (n=6). *Significantly different from control negative (saline) at p<0.05, 
aSignificantly different from control positive (STZ) at p<0.05. Statistical analysis was carried out using one-
way ANOVA test followed by Tukey post hoc test. C. olitorius: Corchorus olitorius, STZ: Streptozotocin.
Figure 2: A photomicrograph of pancreatic tissue using hematoxylin and eosin (H and E): (a) −ve control: Large islet of Langerhans (arrow). 
(b) +ve control: Shrunken, small islet (arrow), degenerated cells (white). (c) Gliclazide improved islet size (arrow) and cellularity. (d) Total alc 
(50 mg): Vacuolated, pyknotic cells, and eosinophilic bodies (white). (e) Total alc (100 mg): Improved islet (arrow). (f) Aq. ext (50 mg): Small 
islet and residual degenerated cells (arrow). (g) Aq. ext (100 mg): Improved islet size and cellularity (arrow). (h) Chloroform (50 mg): Residual 
microvesicular degeneration (black) and scattered hyperchromatic nuclei (white) (i) Chloroform (100 mg): Improved islet (arrow) (H and E, ×400)
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in the form of increase and restoration of number, size, 
as well as increase within the density of cells inside 
the islets. Vacuolar degeneration was diminished and 
necrosis was not seen. Inflammation also decreased. 
Improvement was most marked using total alcoholic 
extract, high dose (Figure 2e), and chloroform extract, 
high dose, approximating normal (Figure 2i), then 
followed by total alcoholic extract, low dose (Figure 2d). 
Improvement was less in the case of aqueous, high 
dose (Figure 2g). No improvement could be noticed 
on treatment with each of chloroform extract; low dose 
(Figure 2h) and aqueous; low dose (Figure 2f).
As shown in Figure 3, the liver tissue of the 
control rat showed preserved architecture. Ordinary, 
polyhedral hepatocytes were seen with ample 
eosinophilic cytoplasm and central, rounded vesicular, 
bland nuclei were seen. Hepatocytes were seen 
disposed in cords, one cell thick each, radiating from 
a central vein, and separated by sinusoids (Figure 3a). 
Liver tissue of positive control rats showed marked 
dilatation and congestion of central veins. Arteries 
showed thick walls. Hepatocytes showed hydropic and 
microvesicular degeneration (Figure 3b). Aggregates 
of inflammatory cells were seen, especially at the 
periphery of dilated vessels. Congestion was seen 
within sinusoids as well. Pyknotic and hyperchromatic 
nuclei were noticed within scattered hepatocytes. 
Liver tissue of diabetic rat treated with reference 
drug (gliclazide) showed remarkable improvement; 
picture approximating negative control (Figure 3c). 
Liver tissue of diabetic rat treated with total alcoholic 
extract; high dose showed considerable improvement, 
still mild congestion was seen within the central vein 
and sinusoids (Figure 3e). The liver tissue of diabetic 
rats treated with chloroform extract; high dose 
showed neither congestion nor dilatation of central 
vein and sinusoids; however, scattered hepatocytes 
showed hyperchromatic nuclei with minimal residual 
microvesicular degeneration (Figure 3i).
Immunohistochemical findings
Islets of Langerhans of diabetic rats showed 
a marked reduction in number, size, and decreased 
density of functioning β-cells as demonstrated by 
an anti-insulin monoclonal antibody (Figure 4b) as 
compared to normal islets (Figure 4a). However, 
diabetic rats treated with C. olitorius chloroform extract 
high dose showed prominent improvement in β-cells 
number, size, and density in the islets of Langerhans 
(Figure 4i). It was better than other extracts (Figure 4d, 
e, f, g, h) and gliclazide (Figure 4c).
Discussion
This study investigates the antidiabetic effects 
of one of the most popular plants cultivated in Egypt, 
Figure 3: A photomicrograph of liver tissue using hematoxylin and eosin (H and E). (a) −ve control: Preserved architecture. (b) +ve control: 
Hydropic degeneration (arrow). (c) Gliclazide: Preserved architecture (arrow). (d) Total alc (50 mg): Mildly congested central vein, scattered 
inflammatory cells. (e) Total alc (100 mg): Mildly congested central vein (thin arrow). (f) Aq. ext. (50 mg): Normal hepatocyte. (g) Aq. Ext. 
(100 mg): Mild congested central vein. (h) Chloroform (50 mg): Mild congestion of dilated central vein, proliferating bile ducts, and normal 
hepatocytes. (i) Chloroform (100 mg): Mildly congested blood sinusoids (thin arrow) and pyknotic hepatocytes (thick arrow) (H and E, ×400)
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C. olitorius. The individual fragmentation pattern of 
C. olitorius aqueous and chloroform extracts showed 
the presence of components from different chemical 
classes. These phytochemicals were reported to have 
pharmacological activities with a potential antidiabetic 
effect such as cinnamic acid and its derivatives, 
coumarins, apigenin, and glycitein. In a recent reported 
study, cinnamic acid and its derivatives were found to be 
associated with protective effects against diabetes and 
its complications [18]. Similarly, coumarins were found to 
possess antidiabetic effects [19]. Apigenin is a member 
of flavones family and showed a hypoglycemic effect in 
STZ-induced diabetic rats through enhancing GLUT4 
translocation and improving the pancreatic architecture, 
suggesting glucose lowering potential of this flavone 
as well as β-cell preserving efficacy [20]. Glycitein is a 
naturally isoflavone with multiple health benefits attributed 
to different biological functions. It has been demonstrated 
that glycitein has an antihyperglycemic effect [21], [22]. 
Theophylline is a potent bronchodilator that acts as 
an adenosine receptor antagonist. Adenosine was 
found to be linked to glucose homeostasis. Adenosine 
1 receptor antagonism improved glucose tolerance 
in Zucker rats through enhancing glucose uptake in 
skeletal muscle [23]. Derivatives of theophylline were 
accordingly synthesized and showed a hypoglycemic 
effect [24].
STZ is a commonly used agent in the induction of 
diabetes in experimental animals [25]. When used at a large 
dose (50–75 mg/kg b.w.), STZ produces the destruction 
of insulin-secreting β-cells through the generation of 
free radicals with methylation of DNA. Structural and 
biochemical alterations developed in this model resemble 
the consequences of Type1 diabetes mellitus [26]. In the 
present study, upon the treatment of diabetic rats with 
the three extracts of C. olitorius, serum glucose level was 
successfully decreased. Histopathological investigation 
revealed that C. olitorius treatment caused remarkable 
improvement in the pancreatic tissue as reflected by an 
increased number, size and density of functioning β-cells. 
Taken together, it may be concluded that this plant act as 
an antihyperglycemic agent through stimulation of β cells 
regeneration or functionality. In previous studies, it was 
shown that the ethanolic seed extract of C. olitorius was 
effective as an antidiabetic remedy [7] and leaf extract 
showed antihyperglycemic effects in type 2 diabetic 
animal model [8].
Alpha-amylase is an enzyme involved in 
carbohydrates digestion. It enhances the hydrolysis 
of glycosidic linkage in some oligosaccharides and 
starch. It breaks down complex polysaccharides into 
oligo- and disaccharides which are further hydrolyzed 
into monosaccharides by α-glucosidase enzyme. 
These simpler forms can be then readily absorbed into 
the portal vein and increase serum glucose levels [27]. 
The activity of the α-amylase enzyme increased in 
the present study by injection of STZ and inhibited by 
the administration of C. olitorius extracts. Inhibition 
of α-amylase keeps carbohydrate digestion and 
monosaccharide absorption controlled. Their digestion 
Figure 4: Immunohistochemical detection of insulin in pancreatic tissue: (a) −ve control rat: Large islets and plenty of b-cells with strong 
intensity and insulin antibody. (b) +ve control: Marked reduction in number, size, and density of β-cells (black arrow) (c) Gliclazide: Marked 
improvement of β-cells. (d) Total alc (50 mg): markedly improved β-cells. (e) Total alc (100 mg): Improved β-cells. (f) Aq. ext. (50 mg): Markedly 
improved of β-cells. (g) Aq. Ext. (100 mg): Increased β-cells. (h) Chloroform (50 mg): Markedly improved β-cells. (i) Chloroform (100 mg): 
Prominently improved β-cells number, size, and density (white arrows) (immunoperoxidase – ×400)
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is delayed and, accordingly, postprandial hyperglycemia 
is alleviated. Therefore, amylase inhibitors are of 
potential therapeutic importance in the treatment of 
diabetes [28]. Hence, the antihyperglycemic capability 
of C. olitorius can be explained, in part, by regulating 
carbohydrate kinetics in vivo through inhibition of 
the α-amylase degrading enzyme. This agrees with 
previous studies that reported the effect of Jute 
leaves on α-amylase but in type 2 diabetes [8]. In 
coincidence with current histopathological findings, 
the antihyperglycemic effect was more pronounced 
in groups treated with chloroform extract than that of 
aqueous fraction, suggesting that it contains more 
active phytochemicals against diabetes.
Treatment with C. olitorius showed antioxidant 
potential, as evidenced by increased TAC. Oxidative 
stress is one of the main mechanisms that mediate 
the deleterious effects of diabetes and eventually 
aggravates diabetic complications. Reactive hydrogen 
peroxide radicals are formed due to glucose oxidation 
and disputation with subsequent generation of 
superoxide anion radicals [29]. Thus, the ability of 
C. olitorius to restore the altered antioxidant status 
reveals its free radical scavenging potential. The 
presence of high contents of flavonoids, saponins, 
carbohydrates, tannins, and triterpenes further 
explains the antioxidant effect of the extracts. These 
phytochemicals act as reducing agents because of their 
strong redox properties, hydrogen donating, and singlet 
oxygen quenching activities [30]. It can be deduced that 
the antioxidant property of C. olitorius extract mediates, 
in part, its antihyperglycemic activity and consequently 
prevention of diabetic complications. The antioxidant 
effect was noticed in both the total alcoholic and its 
chloroform fraction.
Hyperlipidemia is one of the important 
complications of diabetes and plays a major role in 
disease prognosis. At normal conditions, insulin prevents 
the degradation of triglycerides and mobilization of 
fatty acids from fat stores. However, insulin shortage 
enhances lipoprotein lipase inactivation which stimulates 
the assembling of free fatty acids into phospholipids and 
cholesterol, resulting in raising serum lipids. Treatment 
with compounds with lipoprotein lipase enhancing 
effect could suppress elevated serum glucose. The 
proposed mechanism was controlling lipid metabolism 
and improving insulin resistance [31]. In parallel, the 
present lipid profile testing showed an elevation in 
serum levels of total cholesterol, triglycerides, and 
LDL-C, whereas HDL-C decreased in STZ-diabetic 
rats [8]. Treatment with C. olitorius extracts not only 
improved serum phospholipids abnormalities but also 
normalized their values. The aqueous and chloroform 
fraction were equally effective against hyperlipidemia. 
The presence of flavonoids has shown to be associated 
with decreasing the risk of atherosclerosis due to their 
ability to lower cholesterol and triglycerides levels and 
prevention of LDL oxidation [32].
In the present study, the significant increase 
in serum ALT and AST levels that were observed in 
STZ-induced diabetic rats represents liver damage 
compared to negative control rats. Liver necrosis in 
STZ-induced diabetic rats leads to increased plasma 
activities of transaminases due to leakage of these 
enzymes from liver cytosol into the bloodstream [33]. 
Oral administration of C. olitorius showed a protective 
effect on liver tissue by reducing the elevated levels of 
ALT and AST. This is in parallel with a recent investigation 
which showed the hepatoprotective effect of C. olitorius 
and suggested the ability of the plant to maintain the 
integrity of the hepatocellular membrane [34].
Conclusion
The present study explores that suppression 
of α-amylase and antioxidant activity is two proposed 
mechanisms that could mediate the antihyperglycemic 
effect of C. olitorius leaves. This effect varied with 
the different extracts of C. olitorius. The chloroform 
fraction exerted its antidiabetic activity in a dose-
dependent manner and was superior in these effects 
to the aqueous one, indicating the higher efficacy of the 
nonpolar constituents.
C. olitorius total alcoholic extract (at a 
dose of 100 mg/kg) and it is aqueous (at a dose of 
100 mg/kg), and chloroform fractions (at both dose 
levels; 50 and 100 mg/kg) also protected against diabetic 
complications such as hyperlipidemia and determinant 
effects on the liver tissue. These antidiabetic effects 
can be ascribed to the presence of some bioactive 
phytochemical constituents such as theophylline, 
trans-2, 3-dimethoxycinnamic acid, 7-hydroxy-4-methyl 
coumarin, apigenin 7-glucoside, and glycitein. The 
results support the traditional use of this edible plant 
with the additive effect as an antidiabetic remedy.
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